학술논문
Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: Results of the PRO-R-IPI study
Document Type
Article
Author
Source
In: Clinical Lymphoma, Myeloma and Leukemia . (Clinical Lymphoma, Myeloma and Leukemia, 1 July 2015, 15(7):398-403)
Subject
Language
English
ISSN
21522669
21522650
21522650